BiotechWorld Exclusive: Germany’s Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say Last updated: February 10, 2025 10:32 am By Sabrina VallePatricia Weiss Share 0 Min Read Exclusive: Germany’s Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say SHARE - Advertisement - Please enable JS and disable any ad blocker XRP Short Squeeze Could Cost Traders $128M After Ripple, SEC Case Ends Tennis players facing doping charge to get pro bono legal support Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish Canada’s Broken Labour Relations Model Is Costing Us Billions Portland auditor seeks to soften city’s voter-approved campaign finance law to align with state Share This Article Email Copy Link Print Previous Article Exclusive-Germany’s Merck KGaA in Talks to Buy US Cancer Biotech Firm Springworks, Sources Say Next Article Trump Says Talk of Wanting Canada to Be a Part of US Is Serious SearchSearchRecent PostsWhy XRP, already up 40%, just got a bullish signal from this key metric U.S. Small Business Job Growth Remains Consistent in April Export employment to dive if trade war persists -US business group S&P Global to separate its mobility division from parent to streamline business This Ancient Iron Oxide Is Secretly Powering the Next Computing Revolution Recent CommentsNo comments to show.